Acute myeloid leukemia (AML). It's used with cytarabine and daunorubicin hydrochloride in newly diagnosed Older people whose cancer includes a mutation during the FLT3 The organization that markets Rydapt will finish 3 further more research to offer the Company with evidence to support the usefulness with the drugs in elderly https://johnniee085rwa8.vidublog.com/profile